Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Intergroup Pilot Study of Concurrent Carboplatin, Vincristine and Radiotherapy Followed by Adjuvant Chemotherapy in Patients With Newly Diagnosed High-Risk Central Nervous System Embryonal Tumors

NCT00003203 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Intergroup Pilot Study of Concurrent Carboplatin, Vincristine and Radiotherapy Followed by Adjuvant Chemotherapy in Patients With Newly Diagnosed High-Risk Central Nervous System Embryonal Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
March 31, 1998
Completion date
March 31, 2012
Enrollment
168 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors, central nervous system tumors, neuroblastoma